<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jayani RV</submitter><funding>NIA NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><funding>UniHealth Foundation</funding><pagination>3894-3901</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11511632</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>130(22)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Depression and anxiety are prevalent in older adults with cancer but are often undertreated. Older adults are also at increased risk of chemotherapy toxicity (CT). This study evaluated the impact of depression and anxiety symptoms on severe CT risk in older adults with cancer.&lt;h4>Methods&lt;/h4>This is a secondary analysis of a randomized trial (2:1) evaluating geriatric assessment-driven intervention (GAIN) versus standard of care (SOC) to reduce grade 3+ CT in older adults with cancer. Mental health was assessed via the Mental Health Inventory 13. CT was graded by National Cancer Institute Common Terminology Criteria for Adverse Events, version 4.0.&lt;h4>Results&lt;/h4>A total of 605 patients enrolled (402 GAIN; 203 SOC). Overall, 35% were depressed and 47% were anxious. Patie</pubmed_abstract><journal>Cancer</journal><pubmed_title>The relationship of mental health symptoms to chemotherapy toxicity risk in older adults with cancer: Results from the geriatric assessment-driven intervention study.</pubmed_title><pmcid>PMC11511632</pmcid><funding_grant_id>K24AG055693</funding_grant_id><funding_grant_id>R33 AG059206</funding_grant_id><funding_grant_id>R33AG059206</funding_grant_id><funding_grant_id>K24 AG055693</funding_grant_id><pubmed_authors>Cabrera Chien L</pubmed_authors><pubmed_authors>Hamparsumian A</pubmed_authors><pubmed_authors>Li D</pubmed_authors><pubmed_authors>Fernandes Dos Santos Hughes S</pubmed_authors><pubmed_authors>Katheria V</pubmed_authors><pubmed_authors>Sun C</pubmed_authors><pubmed_authors>Moreno J</pubmed_authors><pubmed_authors>Jayani RV</pubmed_authors><pubmed_authors>Taylor WD</pubmed_authors><pubmed_authors>Dale W</pubmed_authors></additional><is_claimable>false</is_claimable><name>The relationship of mental health symptoms to chemotherapy toxicity risk in older adults with cancer: Results from the geriatric assessment-driven intervention study.</name><description>&lt;h4>Background&lt;/h4>Depression and anxiety are prevalent in older adults with cancer but are often undertreated. Older adults are also at increased risk of chemotherapy toxicity (CT). This study evaluated the impact of depression and anxiety symptoms on severe CT risk in older adults with cancer.&lt;h4>Methods&lt;/h4>This is a secondary analysis of a randomized trial (2:1) evaluating geriatric assessment-driven intervention (GAIN) versus standard of care (SOC) to reduce grade 3+ CT in older adults with cancer. Mental health was assessed via the Mental Health Inventory 13. CT was graded by National Cancer Institute Common Terminology Criteria for Adverse Events, version 4.0.&lt;h4>Results&lt;/h4>A total of 605 patients enrolled (402 GAIN; 203 SOC). Overall, 35% were depressed and 47% were anxious. Patie</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-07-15T07:39:47.315Z</modification><creation>2026-07-01T03:07:46.119Z</creation></dates><accession>S-EPMC11511632</accession><cross_references><pubmed>39097801</pubmed><doi>10.1002/cncr.35482</doi></cross_references></HashMap>